- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
BTI delisted from NASDAQ exchange
The stock of magnetic source imaging developer Biomagnetic Technologieshas been taken off the NASDAQ stock exchange effective March 10.The company was found in violation of NASDAQ's listing criteria,which requires firms to have a minimum of $4 million in
The stock of magnetic source imaging developer Biomagnetic Technologieshas been taken off the NASDAQ stock exchange effective March 10.The company was found in violation of NASDAQ's listing criteria,which requires firms to have a minimum of $4 million in net tangibleassets. The company said that its common stock will now be tradedin the over-the-counter market.
San Diego-based BTI has suffered from shipping delays of its Magnes2500 WH system, and restructured in December to conserve cashuntil revenue from Magnes shipments begins to come in (SCAN 2/5/97).For the first quarter of 1997, the vendor reported a $2.1 millionnet loss on revenues of $317,000.
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.
